BioLineRx (BLRX) Return on Capital Employed Growth (3y) (2016 - 2025)
BioLineRx (BLRX) Return on Capital Employed Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4,893.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2,416.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,782.00 |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | 622.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 622.00 |
| Sep 30, 2025 | 42.00 |
| Jun 30, 2025 | -902.00 |
| Mar 31, 2025 | -2,932.00 |
| Dec 31, 2024 | -3,380.00 |
| Sep 30, 2024 | -7,198.00 |
| Jun 30, 2024 | -12,153.00 |
| Mar 31, 2024 | -13,403.00 |
| Dec 31, 2023 | -25,478.00 |
| Sep 30, 2023 | -2,821.00 |
| Jun 30, 2023 | 750.00 |
| Mar 31, 2023 | 2,328.00 |
| Dec 31, 2022 | 2,207.00 |
| Sep 30, 2022 | 1,093.00 |
| Jun 30, 2022 | 205.00 |
| Mar 31, 2022 | 883.00 |
| Dec 31, 2021 | 2,417.00 |
| Sep 30, 2021 | 2,864.00 |
| Jun 30, 2021 | 2,654.00 |
| Mar 31, 2021 | 1,177.00 |